DHHS → node
The Maine Center for Disease Control and Prevention (Maine CDC) offers monthly webinars titled COVID-19 vaccines and therapies. The sessions are offered the second Tuesday of the month at noon. The next session is June 14, 2022.
Enteral nutrition and supply codes that were submitted with overlapping dates, paid by Medicare, and crossed over to MaineCare in the Medicare claim file were denying as duplicates. We have corrected this issue by adding the codes to the Diabetic Supply Service Group. We will adjust affected claims, and no provider action is necessary.
The Maine Pediatric & Behavioral Health Partnership (MPBHP) is looking for your feedback regarding how the Covid-19 pandemic has affected your practice with children and adolescents. If you provide care to this age group, please consider completing this four-question survey. The survey will help us better understand the impact of COVID-19 on providers.
The Office of MaineCare Services (OMS) sent a e-message on May 12, 2022, notifying providers that we are ending Alternative Settings flexibility effective June 6, 2022, as the Centers for Medicare & Medicaid Services (CMS) is terminating state Medicaid agencies’ authority as of that date to approve Alternative Settings
The Maine Department of Health and Human Services is providing up to $4.5 million in funding to eligible behavioral health providers for capital projects that will increase residential treatment for Substance Use Disorder (SUD) capacity in Maine.
In a prior e-message, sent on May 16, 2022, the procedure code for trastuzumab, Herceptin, was incorrectly listed. The correct procedure code is J9355 and is reflected in the updated table below.
In a prior e-message, sent on May 16, 2022, the procedure code for trastuzumab, Herceptin, was incorrectly listed. The correct procedure code is J9355 and is reflected in the updated table below.
The Division of Policy posts all proposed and recently adopted rules on MaineCare’s Policy and Rules webpage. This website keeps the proposed
In a prior e-message, sent on May 16, 2022, the procedure code for trastuzumab, Herceptin, was incorrectly listed. The correct procedure code is J9355 and is reflected in the updated table below.
May 25, 2022
Good Afternoon,
On May 31, we will distribute the DHHS Telework Approval Form. To assist you in filling it out, we have posted slides that will walk you through the approval form. They are available on our Office Re-entry Planning for DHHS Staff site (you can click the link or find them under “About Us” and “Staff”).
You will have until July 1 to fill out the DHHS Form. Supervisors will review the forms from June 20 to July 29.